Author Correction: Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells

NPJ Vaccines. 2024 Jan 11;9(1):13. doi: 10.1038/s41541-024-00804-4.

Julie Zimmermann^#¹, Simon D van Haren^#^{2

3}, Joann Diray-Arce^{2

3}, Ignatius Ryan Adriawan¹, Katharina Wørzner¹, Ricki T Krog¹, Safia Guleed¹, Tu Hu¹, Rasmus Mortensen¹, Jes Dietrich¹, Sara M Ø Solbak⁴, Ofer Levy^{2

3

5}, Dennis Christensen¹, Gabriel K Pedersen^{6

7}

¹ Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark.
² Precision Vaccines Program, Boston Children's Hospital, Boston, MA, 02115, USA.
³ Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
⁴ Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
⁵ Broad Institute of MIT and Harvard, Cambridge, MA, USA.
⁶ Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark. gakp@ssi.dk.
⁷ Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark. gakp@ssi.dk.

^# Contributed equally.

No abstract available

Publication types